Proposed Collection; 60-day Comment Request: Autism Spectrum Disorder Research Portfolio Analysis, 31568-31569 [2013-12420]
Download as PDF
<![CDATA[
mstockstill on DSK4VPTVN1PROD with NOTICES
31568
Federal Register / Vol. 78, No. 101 / Friday, May 24, 2013 / Notices
24. James Cox, Las Cruces, New Mexico,
Court of Federal Claims No: 13–
0238V.
25. Chanel and Paul A. Monroe on
behalf of Angelina Monroe, Las
Vegas, Nevada, Court of Federal
Claims No: 13–0239V.
26. Noteel Koss, Houston, Texas, Court
of Federal Claims No: 13–0240V.
27. Tamika M. Kratzer on behalf of Ian
M. Kratzer, Sacramento, California,
Court of Federal Claims No: 13–
0243V.
28. Rosalie Peck, Boston, Massachusetts,
Court of Federal Claims No: 13–
0249V.
29. Shannon Keller, Sacramento,
California, Court of Federal Claims
No: 13–0250V.
30. Edwina Bradshaw, North Myrtle
Beach, North Carolina, Court of
Federal Claims No: 13–0252V.
31. William and Brenda Lehann
Rodriguez on behalf of C.R.,
Clayton, Georgia, Court of Federal
Claims No: 13–0253V.
32. Corrine K. Ibana, Kamuela, Hawaii,
Court of Federal Claims No: 13–
0257V.
33. Lorel Cubano, San Juan, Puerto Rico,
Court of Federal Claims No: 13–
0259V.
34. Brittany and Davey Lambert on
behalf of Noah Lambert, Memphis,
Tennessee, Court of Federal Claims
No: 13–0265V.
35. Scott and Caroline VanScoy on
behalf of Alyssa VanScoy, Simi
Valley, California, Court of Federal
Claims No: 13–0266V.
36. Jane Sprecher, Reading,
Pennsylvania, Court of Federal
Claims No: 13–0271V.
37. Georgia Murdock, Silver Spring,
Maryland, Court of Federal Claims
No: 13–0273V.
38. Willie Andre Simmons, Augusta,
Georgia, Court of Federal Claims
No: 13–0274V.
39. Jung Park, M.D., New York, New
York, Court of Federal Claims No:
13–0275V.
40. Allison and Steven Council on
behalf of Adam Council, Plainfield,
Illinois, Court of Federal Claims No:
13–0276V.
41. Maryann Giordano, Lindenhurst,
New York, Court of Federal Claims
No: 13–0277V.
42. Laura A. Jones, Greensboro, North
Carolina, Court of Federal Claims
No: 13–0279V.
43. David D. Griffin, Afghanistan, Court
of Federal Claims No: 13–0280V.
44. James Demoski, Endicott, New York,
Court of Federal Claims No: 13–
0286V.
45. Christina N. Steinat, Seattle,
Washington, Court of Federal
Claims No: 13–0287V.
VerDate Mar<15>2010
21:14 May 23, 2013
Jkt 229001
46. Jessica L. Stone, Baraboo,
Wisconsin, Court of Federal Claims
No: 13–0289V.
47. Holly Rhew, Wichita, Kansas, Court
of Federal Claims No: 13–0293V.
48. Janet DeYear, Dallas, Texas, Court of
Federal Claims No: 13–0299V.
49. Cynthia Adkins, Sarasota, Florida,
Court of Federal Claims No: 13–
0295V.
50. Saurabh V. and Archana Amin on
behalf of Sheaa Amin, Linwood,
New Jersey, Court of Federal Claims
No: 13–0300V.
51. Juliet and Mohamed Edoo on behalf
of Justin Edoo, Miami, Florida,
Court of Federal Claims No: 13–
0302V.
52. James Boyer, Boston, Massachusetts,
Court of Federal Claims No: 13–
0303V.
provide interim HIV medical care. The
$429,112 represents a proportional
share of the last award to the
Community Health Care to cover 15
months of HIV medical primary care
services until the service area is
competed for by July 1, 2014.
FOR FURTHER INFORMATION CONTACT: John
Fanning, Public Health Analyst,
Division of Community Based
Programs/Southern Branch, HRSA, by
mail at 5600 Fishers Lane, Rockville,
MD 20857; by email at
jfanning@hrsa.gov; or by phone at (301)
443–0493.
Dated: May 17, 2013.
Mary K. Wakefield,
Administrator.
[FR Doc. 2013–12349 Filed 5–23–13; 8:45 am]
BILLING CODE 4165–15–P
[FR Doc. 2013–12347 Filed 5–23–13; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Health Resources and Services
Administration
Proposed Collection; 60-day Comment
Request: Autism Spectrum Disorder
Research Portfolio Analysis
Ryan White HIV/AIDS Program, Part C
Early Intervention Services Grant
Under the Ryan White HIV/AIDS
Program
Health Resources and Services
Administration (HRSA), Department of
Health and Human Services.
ACTION: Notice of Ryan White HIV/AIDS
Program Part C Early Intervention
Services One-Time Noncompetitive
Award to Ensure Continued HIV
Primary Medical Care.
AGENCY:
To prevent a lapse in
comprehensive primary care services for
persons living with HIV/AIDS, HRSA
will provide a one-time noncompetitive
Ryan White HIV/AIDS Program Part C
funds award to the Genesis Health
Group (GHG), Davenport, Iowa.
SUPPLEMENTARY INFORMATION: The
amount of the award to ensure ongoing
HIV medical services is $429,112.
Authority: Section 2651 of the Public
Health Service Act, 42 U.S.C. 300ff–51
CFDA Number: 93.918
Project period: The period of support
for this award is 15 months, explained
below in further detail.
Justification for the Exception to
Competition: The Community Health
Care, Davenport, Iowa (Grant Number:
H76HA00212) announced the
relinquishment of their Part C grant on
January 31, 2013. To prevent a lapse in
HIV medical care, grant funds of
$429,112 are to be awarded to GHG to
SUMMARY:
PO 00000
Frm 00054
Fmt 4703
Sfmt 4703
In compliance with the
requirement of Section 3506(c)(2)(A) of
the Paperwork Reduction Act of 1995,
for opportunity for public comment on
proposed data collection projects, the
National Institute of Mental Health
(NIMH), the National Institutes of
Health (NIH) will publish periodic
summaries of proposed projects to be
submitted to the Office of Management
and Budget (OMB) for review and
approval.
Written comments and/or suggestions
from the public and affected agencies
are invited to address one or more of the
following points: (1) Whether the
proposed collection of information is
necessary for the proper performance of
the function of the agency, including
whether the information will have
practical utility; (2) The accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used; (3)
The quality, utility, and clarity of the
information to be collected; and (4)
Minimize the burden of the collection of
information on those who are to
respond, including the use of
appropriate automated, electronic,
mechanical, or other technological
collection techniques or other forms of
information technology.
To Submit Comments and For Further
Information: To obtain a copy of the
data collection plans and instruments,
submit comments in writing, or request
SUMMARY:
E:\FR\FM\24MYN1.SGM
24MYN1
31569
Federal Register / Vol. 78, No. 101 / Friday, May 24, 2013 / Notices
more information on the proposed
project, contact: The Office of Autism
Research Coordination, NIMH, NIH,
Neuroscience Center, 6001 Executive
Blvd., MSC 9663, Room 6184, Bethesda,
MD 20892 or Email your request,
including your address to:
iaccpublicinquiries@mail.nih.gov.
Formal requests for additional plans and
instruments must be requested in
writing.
Comment Due Date: Comments
regarding this information collection are
best assured of having their full effect if
received within 60 days of the date of
this publication.
stakeholders of the funding landscape
and current directions for ASD research.
Specifically, these analyses will
examine the extent to which current
funding and research topics align with
the IACC Strategic Plan for ASD
Research. The findings will help guide
future funding priorities by outlining
current gaps and opportunities in ASD
research as well as serving to highlight
annual activities and research progress.
OMB approval is requested for three
years. There are no costs to respondents
other than their time. The total
estimated annualized burden hours are
419.
Proposed Collection: Autism
Spectrum Disorder (ASD) Research
Portfolio Analysis, 0925—NEW—
National Institute of Mental Health
(NIMH), National Institutes of Health
(NIH).
Need and Use of Information
Collection: The purpose of the ASD
portfolio analysis is to collect research
funding data from U.S. and
international ASD research funders, to
assist the Interagency Autism
Coordinating Committee (IACC) in
fulfilling the requirements of the
Combating Autism Act, and to inform
the committee and interested
ESTIMATED ANNUALIZED BURDEN HOURS
Type of respondents
(funders)
Number of
respondents
U.S. Federal .....................................................................................................
U.S. Private ......................................................................................................
International Government ................................................................................
International Private .........................................................................................
Dated: March 26, 2013.
Sue Murrin,
Executive Officer, NIMH, NIH.
[FR Doc. 2013–12420 Filed 5–23–13; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
mstockstill on DSK4VPTVN1PROD with NOTICES
National Cancer Institute; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications/
contract proposals and the discussions
could disclose confidential trade secrets
or commercial property such as
patentable material, and personal
information concerning individuals
associated with the grant applications,
the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Cancer
Institute Special Emphasis Panel, AIDS and
Cancer Specimen Resource (ACSR)
Date: May 29, 2013
Time: 12:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications
VerDate Mar<15>2010
22:20 May 23, 2013
Jkt 229001
26
12
4
4
Place: National Cancer Institute Shady
Grove, Shady Grove, 9609 Medical Center
Drive, Room 1E030, Rockville, MD 20850
(Telephone Conference Call)
Contact Person: Donald L Coppock, Ph.D.,
Scientific Review Officer, Special Review
and Logistics Branch, Division of Extramural
Activities, National Cancer Institute, Shady
Grove–NIH, 9609 Medical Center Drive,
Room 7W260, Bethesda, MD 20892, 240–
276–6382, donald.coppock@nih.gov
This notice is being published less than 15
days prior to the meeting date due to
scheduling conflicts.
Name of Committee: National Cancer
Institute Special Emphasis Panel, NCI
Program Project Meeting II
Date: June 12–13, 2013
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications
Place: Hilton, Rockville, 1750 Rockville
Pike, Rockville, MD 20852
Contact Person: Majed M. Hamawy, Ph.D.,
Scientific Review Officer, Research Programs
Review Branch, Division Of Extramural
Activities, National Cancer Institute, NIH,
9609 Medical Center Drive, Room 7W120,
Bethesda, MD 20892, 240–276–6457,
mh101v@nih.gov
Name of Committee: National Cancer
Institute Special Emphasis Panel, Innovative
Technologies for Cancer Biospecimen
Science
Date: June 12, 2013
Time: 12:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications
Place: National Cancer Institute—Shady
Grove, Shady Grove, 9609 Medical Center
Drive, Room 1E030, Rockville, MD 20850
(Telephone Conference Call)
Contact Person: Donald L Coppock, Ph.D.,
Scientific Review Officer, Special Review
PO 00000
Frm 00055
Fmt 4703
Sfmt 4703
Number of
response per
respondent
36
54
14
9
Average Time
per Response
(in hours)
15/60
15/60
15/60
15/60
Total burden
hours
234
162
14
9
and Logistics Branch, Division of Extramural
Activities, National Cancer Institute, NIH,
9609 Medical Center Drive, Room 7W260,
Bethesda, MD 20892, 240–276–6382,
donald.coppock@nih.gov
Name of Committee: National Cancer
Institute Special Emphasis Panel, RNA
Biosensor
Date: June 13, 2013
Time: 1:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate contract
proposals
Place: National Cancer Institute Shady
Grove, Shady Grove, 9609 Medical Center
Drive, Room 6W034, Rockville, MD 20850
(Telephone Conference Call)
Contact Person: Bratin K. Saha, Ph.D.,
Scientific Review Officer, Program
Coordination and Referral Branch, Division
of Extramural Activities, National Cancer
Institute, NIH, 9609 Medical Center Drive,
Room 7W556, Bethesda, MD 20892, 240–
276–6411, sahab@mail.nih.gov
Name of Committee: National Cancer
Institute Special Emphasis Panel, R13
Review Teleconference
Date: June 25, 2013
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute Shady
Grove, Shady Grove, 9609 Medical Center
Drive, Room 6W034, Rockville, MD 20850
(Telephone Conference Call)
Contact Person: Bratin K. Saha, Ph.D.,
Scientific Review Officer, Program
Coordination and Referral Branch, Division
of Extramural Activities, National Cancer
Institute, NIH, 9609 Medical Center Drive,
Room 7W556, Bethesda, MD 20892, 240–
276–6411, sahab@mail.nih.gov
Name of Committee: National Cancer
Institute Special Emphasis Panel, NCI
Omnibus Biology
Date: July 15–16, 2013
E:\FR\FM\24MYN1.SGM
24MYN1
]]>Agencies
[Federal Register Volume 78, Number 101 (Friday, May 24, 2013)]
[Notices]
[Pages 31568-31569]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-12420]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Proposed Collection; 60-day Comment Request: Autism Spectrum
Disorder Research Portfolio Analysis
SUMMARY: In compliance with the requirement of Section 3506(c)(2)(A) of
the Paperwork Reduction Act of 1995, for opportunity for public comment
on proposed data collection projects, the National Institute of Mental
Health (NIMH), the National Institutes of Health (NIH) will publish
periodic summaries of proposed projects to be submitted to the Office
of Management and Budget (OMB) for review and approval.
Written comments and/or suggestions from the public and affected
agencies are invited to address one or more of the following points:
(1) Whether the proposed collection of information is necessary for the
proper performance of the function of the agency, including whether the
information will have practical utility; (2) The accuracy of the
agency's estimate of the burden of the proposed collection of
information, including the validity of the methodology and assumptions
used; (3) The quality, utility, and clarity of the information to be
collected; and (4) Minimize the burden of the collection of information
on those who are to respond, including the use of appropriate
automated, electronic, mechanical, or other technological collection
techniques or other forms of information technology.
To Submit Comments and For Further Information: To obtain a copy of
the data collection plans and instruments, submit comments in writing,
or request
[[Page 31569]]
more information on the proposed project, contact: The Office of Autism
Research Coordination, NIMH, NIH, Neuroscience Center, 6001 Executive
Blvd., MSC 9663, Room 6184, Bethesda, MD 20892 or Email your request,
including your address to: iaccpublicinquiries@mail.nih.gov. Formal
requests for additional plans and instruments must be requested in
writing.
Comment Due Date: Comments regarding this information collection
are best assured of having their full effect if received within 60 days
of the date of this publication.
Proposed Collection: Autism Spectrum Disorder (ASD) Research
Portfolio Analysis, 0925--NEW--National Institute of Mental Health
(NIMH), National Institutes of Health (NIH).
Need and Use of Information Collection: The purpose of the ASD
portfolio analysis is to collect research funding data from U.S. and
international ASD research funders, to assist the Interagency Autism
Coordinating Committee (IACC) in fulfilling the requirements of the
Combating Autism Act, and to inform the committee and interested
stakeholders of the funding landscape and current directions for ASD
research. Specifically, these analyses will examine the extent to which
current funding and research topics align with the IACC Strategic Plan
for ASD Research. The findings will help guide future funding
priorities by outlining current gaps and opportunities in ASD research
as well as serving to highlight annual activities and research
progress.
OMB approval is requested for three years. There are no costs to
respondents other than their time. The total estimated annualized
burden hours are 419.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average Time
Type of respondents (funders) Number of response per per Response Total burden
respondents respondent (in hours) hours
----------------------------------------------------------------------------------------------------------------
U.S. Federal.................................... 26 36 15/60 234
U.S. Private.................................... 12 54 15/60 162
International Government........................ 4 14 15/60 14
International Private........................... 4 9 15/60 9
----------------------------------------------------------------------------------------------------------------
Dated: March 26, 2013.
Sue Murrin,
Executive Officer, NIMH, NIH.
[FR Doc. 2013-12420 Filed 5-23-13; 8:45 am]
BILLING CODE 4140-01-P
